Published in BMJ on May 02, 2014
Effects of Centralizing Acute Stroke Services on Stroke Care Provision in Two Large Metropolitan Areas in England. Stroke (2015) 0.89
Operational research as implementation science: definitions, challenges and research priorities. Implement Sci (2016) 0.88
Improving acute stroke services in the Netherlands. BMJ (2014) 0.75
A modelling tool for capacity planning in acute and community stroke services. BMC Health Serv Res (2016) 0.75
A multidimensional conceptual framework for analysing public involvement in health services research. Health Expect (2008) 2.93
Acupuncture for subacute stroke rehabilitation: a Sham-controlled, subject- and assessor-blind, randomized trial. Arch Intern Med (2005) 1.92
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol (2010) 1.76
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU Int (2011) 1.51
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value Health (2011) 1.48
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant (2007) 1.47
Anticoagulation for atrial fibrillation: should warfarin be temporarily stopped or continued after acute cardioembolic stroke? Age Ageing (2010) 1.40
Public health implications of establishing a national programme to screen young athletes in the UK. Br J Sports Med (2009) 1.38
The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs (2008) 1.21
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2013) 1.15
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2008) 1.11
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness. Am J Rhinol (2006) 1.11
Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies. Implement Sci (2012) 1.06
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract (2006) 1.05
Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care (2012) 1.03
Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev (2011) 1.02
Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke (2012) 1.01
Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health (2009) 0.92
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review. BMC Health Serv Res (2013) 0.92
Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction. BMC Health Serv Res (2013) 0.92
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics (2008) 0.90
The clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review. PLoS One (2013) 0.90
Effectiveness of mealtime interventions on nutritional outcomes for the elderly living in residential care: a systematic review and meta-analysis. Ageing Res Rev (2013) 0.89
Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. Pharmacoeconomics (2005) 0.89
Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis? Stroke (2012) 0.89
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics (2013) 0.88
How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy? Cerebrovasc Dis (2006) 0.88
Chemotherapeutic wafers for High Grade Glioma. Cochrane Database Syst Rev (2008) 0.88
A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG (2004) 0.87
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis. BMC Geriatr (2014) 0.87
Implementing the evidence for preventing falls among community-dwelling older people: a systematic review. J Safety Res (2011) 0.87
Does telephone follow-up improve blood pressure after minor stroke or TIA? Age Ageing (2010) 0.86
Establishing local priorities for a health research agenda. Health Expect (2012) 0.85
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health (2009) 0.84
Interventions to reduce acute paediatric hospital admissions: a systematic review. Arch Dis Child (2012) 0.84
Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract (2006) 0.83
Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction? Int J Cardiol (2008) 0.83
Better prevention of stroke through screening for atrial fibrillation. Br J Gen Pract (2012) 0.79
Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care (2012) 0.79
Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial. Clin Rehabil (2010) 0.78
Involving patients in drug licensing decisions. BMJ (2013) 0.77
A modelling tool for capacity planning in acute and community stroke services. BMC Health Serv Res (2016) 0.75
Predictive value of asthma medication to identify asthma sufferers. Br J Gen Pract (2002) 0.75
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis. Pharmacoeconomics (2012) 0.75
NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Lancet Oncol (2011) 0.75
Adult attention deficit hyperactivity disorder (ADHD): public health implications. Perspect Public Health (2012) 0.75
Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review. BJOG (2005) 0.75
Mind sharpeners for scientists: the EQUATOR Network. Int J Technol Assess Health Care (2011) 0.75
Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care (2009) 0.75
Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis. Pharmacoeconomics (2015) 0.75
A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula. J Public Health (Oxf) (2007) 0.75
The 7th IMA international conference on quantitative modelling in the management of health and social care: IMA health 2013 special issue. Health Care Manag Sci (2014) 0.75